Table 5.
Clinical characteristics of Stage Ib patients
| No. | Age (year) | Initial surgery | Surgical route | Histological type | Grade | Platinum-based chemotherapy | Follow-up time (month) | Status |
| 1 | 33 | USO+BO+OM | Lap | Serous | 2 | Yes | 61 | NED |
| 2 | 28 | BC | Exp | Endometrioid | 2 | Yes | 62 | NED |
| 3 | 28 | BC | Exp | Serous | 2 | Yes | 70 | NED |
| 4 | 34 | BC | Exp | Serous | 2 | Yes* | 45 | NED |
| 5 | 38 | BC | Lap | Serous | 2 | Yes | 28 | NED |
| 6 | 21 | BC | Exp | Mucinous | 1 | Yes | 15 | NED |
| 7 | 20 | USO+BO+OM+PLND/PALND | Lap | Mixed | NG | Yes | 13 | NED |
| 8 | 21 | BC | Exp | Endometrioid | NG | Yes | 197 | NED |
USO: unilateral salpingo-oophorectomy; BO: biopsy from the opposite ovarian; OM: omentectomy; BC: bilateral cystectomy; PLND/PALND: pelvic/para-aortic lymph nodes dissection or biopsy; Lap: laparoscopy; Exp: exploration; NG: not graded; NED: no evidence of the disease
*
Non-standard platinum-based chemotherapy